Statement from Dr Rodney Baber, President IMS re the recent report on ovarian cancer risk associated with HRT usage published in The Lancet, 13th February 2015 “This meta-analysis of 52 epidemiological studies has repo - Dydrogesterone - Document - PDFSEARCH.IO

First Page	Meta Content
	Statement from Dr Rodney Baber, President IMS re the recent report on ovarian cancer risk associated with HRT usage published in The Lancet, 13th February 2015 “This meta-analysis of 52 epidemiological studies has repo Add to Reading List Document Date: 2015-02-16 13:39:01 Open Document File Size: 87,83 KB Share Result on Facebook Country United Kingdom / Denmark / / / / MedicalCondition mucinous ovarian cancer / ovarian cancers / ovarian cancer / epithelial ovarian cancer / / MedicalTreatment HRT / / Person Rodney Baber / Lee Tomkins / / / Position IMS Executive Director / President / author / leetomkinsims@btinternet.com CIO / Director / PO Box / / SocialTag Menopause The Million Women Study Dydrogesterone Medicine Gynaecological cancer Ovarian cancer

Statement from Dr Rodney Baber, President IMS re the recent report on ovarian cancer risk associated with HRT usage published in The Lancet, 13th February 2015 “This meta-analysis of 52 epidemiological studies has repoAdd to Reading List